Substack Publication | The Obesity Series, Part IV: Engineering the Meal
Part IV of Ten Ten Ten’s seven-part Obesity Series is now live. Americans are not eating more simply because they grew hungrier. Over the past five decades, restaurants and food companies deliberately enlarged portions because adding more fries, soda, and other inexpensive calories costs very little while increasing the perceived value and profitability of a […]
Ten Ten Ten Announces Free Value-Based Care Playbook for Independent Primary Care Practices
PITTSBURGH – June 26, 2026 – PRLog — Ten Ten Ten, a nonprofit organization focused on improving U.S. health outcomes while reducing healthcare spending, today announced the launch of its free Value-Based Care Playbook for independent primary care practices. The playbook is designed to help independent practices evaluate, prepare for, and participate in value-based care arrangements without being locked into a […]
Cofounder Bhargav Raman presents at InnovatorMD
In this presentation to the InnovatorMD audience, Bhargav Raman, MD, MBA, co-founder of Ten Ten Ten, introduces the Ten Ten Ten Certification Program and its role in accelerating meaningful healthcare transformation. The program recognizes organizations, clinicians, and innovators that are measurably improving health outcomes, reducing total healthcare costs, and advancing equity and access. Bhargav explains […]
Substack Publication | The Obesity Series, Part III: Subsidizing Sweetness
Part III of Ten Ten Ten’s seven-part Obesity Series is now live. Federal agricultural policy helps make corn cheap. The food industry converts that corn into high-fructose corn syrup, which appears throughout the American diet, particularly in sodas and ultra-processed foods. This is not a simple story about one ingredient causing one disease. Obesity is […]
Title: Substack Publication | The Obesity Series, Part II: GLP-1s: Symptom Treatment vs Systems Change
Part II of Ten Ten Ten’s seven-part Obesity Series is now live. GLP-1 medications are genuine medical breakthroughs. They can produce significant weight loss, reduce cardiovascular risk, and improve the lives of people with clinical obesity. But they do not change the food system, built environment, or economic incentives that helped create America’s obesity crisis. […]
Substack Publication | The Obesity Series, Part I: The Obesity Equation
Ten Ten Ten is launching a new seven-part series examining one of America’s most consequential and misunderstood health crises: obesity. Part I, “The Obesity Equation,” begins with a central truth: America’s weight crisis is not simply a failure of individual willpower. It is the predictable result of a food system designed to encourage overconsumption and […]
Prevention, Lifestyle, and the Ten Ten Ten Path to Better Outcomes at Lower Cost
A conversation with Michael Parkinson, MD, MPH, Colonel, USAF (Ret.) Ten Ten Ten Advisor, Preventive Medicine and Chronic Disease In this conversation, T.J. Tedesco of Ten Ten Ten sits down with Michael Parkinson, MD, MPH, Colonel, USAF (Ret.), to discuss whether America can improve health outcomes and lower healthcare costs at the same time, and […]
Ten Ten Ten Featured on The Health Care Blog
We recently joined Matthew Holt on The Health Care Blog for a thoughtful, candid conversation about Ten Ten Ten and the case for a clearer North Star in U.S. healthcare. The discussion explored a core premise behind the initiative: the United States cannot incrementalize its way out of a system that delivers mid-tier outcomes at […]
The Cinder Block Paradox
In 1890, inventor Harmon Palmer looked at a solid concrete block and asked a simple question: What would happen if you removed material from the center? The result was a design that performed better in several ways. The hollow block was lighter and easier to handle, and the air trapped inside improved insulation, keeping buildings […]
When oncology ads land on someone who actually reads the data…
Perjeta + trastuzumab in early HER2‑positive breast cancer delivers a 1.8% absolute overall‑survival benefit at 10 years — and only in high risk node‑positive patients.That means 100 people get a year of dual‑antibody toxicity, so that 2 benefit over ten years. This result was just barely statistically significant, and only in a subgroup that represents […]